You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase 1b

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Sarcoidosis Trial (XTMAB-16 or Placebo)

Not yet recruiting
  • Pulmonary Sarcoidosis
  • XTMAB-16 or Placebo
  • (no location specified)
May 25, 2023

Acute Myeloid Leukemia Trial in Houston (ASTX727, ASTX029-01)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    MD Anderson Cancer Center
Oct 27, 2023

Alcohol Use Disorder Trial in Glendale (DCR-AUD, Placebo)

Active, not recruiting
  • Alcohol Use Disorder
  • Glendale, California
    Parexel Los Angeles Early Phase Clinical Unit
Apr 26, 2023

Chronic Inducible Urticaria Trial in Canada, United States (Oral EP262)

Recruiting
  • Chronic Inducible Urticaria
  • Oral EP262
  • Tampa, Florida
  • +5 more
Sep 18, 2023

Ulcerative Colitis Trial in Whittier (APL-1401, Placebo)

Not yet recruiting
  • Ulcerative Colitis
  • Whittier, California
    New Hope Research Development
Feb 15, 2023

Leprosy Trial in Rio de Janeiro (LEP-F1 + GLA-SE, Placebo)

Not yet recruiting
  • Leprosy
  • LEP-F1 + GLA-SE
  • Placebo
  • Rio de Janeiro, Brazil
    Veronica Schmitz Pereira
Dec 5, 2022

Vanishing White Matter Disease Trial in Salt Lake City (ABBV-CLS-7262)

Recruiting
  • Vanishing White Matter Disease
  • Salt Lake City, Utah
    University of Utah Hospital
Mar 6, 2023

Head Neck Cancer Trial in Billerica, Darmstadt (Xevinapant, Cisplatin, intensity-modulated radiation therapy (IMRT))

Not yet recruiting
  • Head and Neck Cancer
  • Billerica, Massachusetts
  • +1 more
Sep 20, 2023

Metastatic Breast Cancer Trial in Pompano Beach, Caracas (ConvitVax)

Not yet recruiting
  • Metastatic Breast Cancer
  • ConvitVax
  • Pompano Beach, Florida
  • +2 more
Aug 28, 2023

RAS Mutation, NRAS Gene Mutation, Melanoma Trial in Phoenix, Newnan, Zion (OKI-179 + binimetinib)

Recruiting
  • RAS Mutation
  • +2 more
  • OKI-179 + binimetinib
  • Phoenix, Arizona
  • +4 more
Sep 22, 2022

Squamous Cell Carcinoma, RP1 Trial (RP1)

Not yet recruiting
  • Squamous Cell Carcinoma
  • RP1
  • (no location specified)
May 4, 2023

Breast Tumors Trial in Shanghai (ZN-c5)

Completed
  • Breast Neoplasms
  • Shanghai, China
    Fudan University Cancer Hospital
Aug 10, 2022

Recurrent Glioblastoma Trial in Heidelberg, Nedlands (TTAC-0001 and pembrolizumab combination)

Active, not recruiting
  • Recurrent Glioblastoma
  • TTAC-0001 and pembrolizumab combination
  • Heidelberg, Victoria, Australia
  • +1 more
Aug 15, 2022

Cystic Fibrosis Trial in Christchurch (ABCI, Placebo)

Recruiting
  • Cystic Fibrosis
  • ABCI
  • Placebo
  • Christchurch, New Zealand
    New Zealand Clinical Research
Apr 4, 2023

Colorectal Cancer Metastatic, Squamous Cell Carcinoma of Head and Neck Trial (WU-NK-101 - Dose Escalation, Cetuximab - Dose

Not yet recruiting
  • Colorectal Cancer Metastatic
  • Squamous Cell Carcinoma of Head and Neck
  • WU-NK-101 - Dose Escalation
  • +3 more
  • (no location specified)
Dec 30, 2022

Ovarian Cancer Trial in Houston (Paclitaxel, Bevacizumab, Lurbinectedin)

Not yet recruiting
  • Ovarian Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Nov 23, 2022

Metastatic Pancreatic Carcinoma Trial in Providence (CAR2 Anti-CEA CAR-T cells)

Terminated
  • Metastatic Pancreatic Carcinoma
  • CAR2 Anti-CEA CAR-T cells
  • Providence, Rhode Island
    Roger Williams Medical Center
Jan 12, 2023

Colorectal Cancer Trial (ME-344, Bevacizumab)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Apr 20, 2023

Cholangiocarcinoma Trial (GNS561 + Trametinib)

Not yet recruiting
  • Cholangiocarcinoma
  • GNS561 + Trametinib
  • (no location specified)
May 22, 2023

Breast Cancer Trial in Houston (Trastuzumab deruxtecan, Valemetostat)

Not yet recruiting
  • Breast Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Dec 14, 2022

Metastatic Breast Cancer Trial (Olaparib, 17b-estradiol)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Jun 2, 2023

Metastatic Colorectal Cancer Trial in Houston (Cetuximab, Ulixertinib, Encorafenib)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2023

Rheumatoid Arthritis, Arthritis, Rheumatoid, Arthritis Trial in United States (Imvotamab, Placebo)

Recruiting
  • Rheumatoid Arthritis
  • +2 more
  • Anniston, Alabama
  • +6 more
Oct 11, 2023

Overweight or Obesity Trial in United States (GSBR-1290, Placebo)

Recruiting
  • Overweight or Obesity
  • Anaheim, California
  • +3 more
Feb 28, 2023

Healthy Trial in Pretoria (H107e, CAF®10b, H107e/CAF®10b - low adjuvant dose)

Not yet recruiting
  • Healthy
  • H107e
  • +10 more
  • Pretoria, Gauteng, South Africa
    Aurum Institute
Sep 24, 2023